- IBD
-
Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions
-
Harris A. Ahmad, James E. East, Remo Panaccione, Simon Travis, James B. Canavan, Keith Usiskin, Michael F. Byrne
-
Intest Res 2023;21(3):283-294. Published online April 20, 2023
-
DOI: https://doi.org/10.5217/ir.2023.00020
-
-
 Abstract
 PDF PubReader ePub
- Inflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis and is characterized by uncontrolled, relapsing, and remitting course of inflammation in the gastrointestinal tract. Artificial intelligence represents a new era within the field of gastroenterology, and the amount of research surrounding artificial intelligence in patients with inflammatory bowel disease is on the rise. As clinical trial outcomes and treatment targets evolve in inflammatory bowel disease, artificial intelligence may prove as a valuable tool for providing accurate, consistent, and reproducible evaluations of endoscopic appearance and histologic activity, thereby optimizing the diagnosis process and identifying disease severity. Furthermore, as the applications of artificial intelligence for inflammatory bowel disease continue to expand, they may present an ideal opportunity for improving disease management by predicting treatment response to biologic therapies and for refining the standard of care by setting the basis for future treatment personalization and cost reduction. The purpose of this review is to provide an overview of the unmet needs in the management of inflammatory bowel disease in clinical practice and how artificial intelligence tools can address these gaps to transform patient care.
-
Citations
Citations to this article as recorded by  - Deep Learning Model Using Stool Pictures for Predicting Endoscopic Mucosal Inflammation in Patients With Ulcerative Colitis
Jung Won Lee, Dongwon Woo, Kyeong Ok Kim, Eun Soo Kim, Sung Kook Kim, Hyun Seok Lee, Ben Kang, Yoo Jin Lee, Jeongseok Kim, Byung Ik Jang, Eun Young Kim, Hyeong Ho Jo, Yun Jin Chung, Hanjun Ryu, Soo-Kyung Park, Dong-Il Park, Hosang Yu, Sungmoon Jeong
American Journal of Gastroenterology.2025; 120(1): 213. CrossRef - The Role of Artificial Intelligence and Big Data for Gastrointestinal Disease
Nicholas Mathew Holt, Michael Francis Byrne
Gastrointestinal Endoscopy Clinics of North America.2025; 35(2): 291. CrossRef - Ulcerative Colitis Severity Classification and Localized Extent (UC-SCALE): An Artificial Intelligence Scoring System for a Spatial Assessment of Disease Severity in Ulcerative Colitis
Benjamin Gutierrez-Becker, Stefan Fraessle, Heming Yao, Jerome Luscher, Rafal Girycki, Bartosz Machura, Janusz Czornik, Jaroslaw Goslinsky, Marek Pitura, Steven Levitte, Josep Arús-Pous, Emily Fisher, Daniela Bojic, David Richmond, Amelie E Bigorgne, Marc
Journal of Crohn's and Colitis.2025;[Epub] CrossRef - Artificial intelligence–enabled histology exhibits comparable accuracy to pathologists in assessing histological remission in ulcerative colitis: a systematic review, meta-analysis, and meta-regression
Miguel Puga-Tejada, Snehali Majumder, Yasuharu Maeda, Irene Zammarchi, Ilaria Ditonno, Giovanni Santacroce, Ivan Capobianco, Carlos Robles-Medranda, Subrata Ghosh, Marietta Iacucci
Journal of Crohn's and Colitis.2025;[Epub] CrossRef - Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
Rocio Sedano, Virginia Solitano, Sudheer K. Vuyyuru, Yuhong Yuan, Jurij Hanžel, Christopher Ma, Olga Maria Nardone, Vipul Jairath
Therapeutic Advances in Gastroenterology.2025;[Epub] CrossRef - The global research of artificial intelligence on inflammatory bowel disease: A bibliometric analysis
Suqi Zeng, Chenyu Dong, Chuan Liu, Junhai Zhen, Yu Pu, Jiaming Hu, Weiguo Dong
DIGITAL HEALTH.2025;[Epub] CrossRef - Rediscovering histology – the application of artificial intelligence in inflammatory bowel disease histologic assessment
Giovanni Santacroce, Irene Zammarchi, Olga Maria Nardone, Ivan Capobianco, Miguel Puga-Tejada, Snehali Majumder, Subrata Ghosh, Marietta Iacucci
Therapeutic Advances in Gastroenterology.2025;[Epub] CrossRef - Possibilities of using artificial intelligence technologies in the morphological diagnosis of inflammatory bowel diseases (literature review)
E. G. Churilova, A. B. Kazumova, Kh. M. Akhrieva, N. V. Pachuasvili, A. S. Tertychnyy
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2025; 15(1): 22. CrossRef - Mining Transcriptional Data for Precision Medicine: Bioinformatics Insights into Inflammatory Bowel Disease
Arman Shahriari, Shokoofeh Amirzadeh Shams, Hamidreza Mahboobi, Maryam Yazdanparast, Amirreza Jabbaripour Sarmadian
Current Bioinformatics.2025; 20(4): 289. CrossRef - The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model
Yuichiro Hamamoto, Michihiro Kawamura, Hiroki Uchida, Kazuhiro Hiramatsu, Chiaki Katori, Hinako Asai, Shigeki Shimizu, Satoshi Egawa, Kyotaro Yoshida
International Journal of Surgical Pathology.2024; 32(5): 890. CrossRef - Could histologic healing be a new treatment target in patients with ulcerative colitis?
Soyoung Kim, Sang Hyoung Park
The Korean Journal of Internal Medicine.2024; 39(1): 2. CrossRef - Machine learning in the assessment and management of acute gastrointestinal bleeding
Gaurav Bhaskar Nigam, Michael F Murphy, Simon P L Travis, Adrian J Stanley
BMJ Medicine.2024; 3(1): e000699. CrossRef - The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis
Petar Uchikov, Usman Khalid, Nikola Vankov, Maria Kraeva, Krasimir Kraev, Bozhidar Hristov, Milena Sandeva, Snezhanka Dragusheva, Dzhevdet Chakarov, Petko Petrov, Bistra Dobreva-Yatseva, Ivan Novakov
Diagnostics.2024; 14(10): 1004. CrossRef - Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease
Marietta Iacucci, Giovanni Santacroce, Irene Zammarchi, Yasuharu Maeda, Rocío Del Amor, Pablo Meseguer, Bisi Bode Kolawole, Ujwala Chaudhari, Antonio Di Sabatino, Silvio Danese, Yuichi Mori, Enrico Grisan, Valery Naranjo, Subrata Ghosh
The Lancet Gastroenterology & Hepatology.2024; 9(8): 758. CrossRef - Summary of the best evidence on self-management support schemes for patients with inflammatory bowel disease based on mobile health systems
Chenfei Ren, Yunxian Zhou, Qian Cai, Mi Zhou
DIGITAL HEALTH.2024;[Epub] CrossRef - Deep Learning-Based Real-Time Organ Localization and Transit Time Estimation in Wireless Capsule Endoscopy
Seung-Joo Nam, Gwiseong Moon, Jung-Hwan Park, Yoon Kim, Yun Jeong Lim, Hyun-Soo Choi
Biomedicines.2024; 12(8): 1704. CrossRef - Dye-based chromoendoscopy detects more neoplasia than white light endoscopy
in patients with primary sclerosing cholangitis and IBD
Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East
Endoscopy International Open.2024; 12(11): E1285. CrossRef - Potential Oral Microbial Markers for Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis Using Machine Learning Models
Sang-Bum Kang, Hyeonwoo Kim, Sangsoo Kim, Jiwon Kim, Soo-Kyung Park, Chil-Woo Lee, Kyeong Ok Kim, Geom-Seog Seo, Min Suk Kim, Jae Myung Cha, Ja Seol Koo, Dong-Il Park
Microorganisms.2023; 11(7): 1665. CrossRef
-
7,286
View
-
377
Download
-
16
Web of Science
-
18
Crossref
-
Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
-
Paulo Gustavo Kotze, Subrata Ghosh, Willem A. Bemelman, Remo Panaccione
-
Intest Res 2017;15(2):160-165. Published online April 27, 2017
-
DOI: https://doi.org/10.5217/ir.2017.15.2.160
-
-
Abstract
PDFPubReaderePub
Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide. However, a significant proportion of patients still need surgical resections. The impact of previous exposure to these agents on the perioperative and postoperative outcomes is still controversial. In this critical review, we aimed to position the strategy of intentional preoperative use of anti-TNF agents in the management of CD. The indications and contraindications for this strategy are detailed, and despite scarce evidence, the possible advantages and disadvantages of the intentional use of anti-TNF agents before abdominal surgery in CD are discussed. -
Citations
Citations to this article as recorded by - Clinical guidelines. Crohn’s disease (К50), adults
Yury A. Shelygin, Vladimir T. Ivashkin, Sergey I. Achkasov, Igor V. Reshetov, Igor V. Maev, Elena A. Belousova, Armen V. Vardanyan, Bella A. Nanaeva, Leila V. Adamyan, Oksana M. Drapkina, Leila S. Namazova-Baranova, Aleksandr Yu. Razumovsky, Amiran Sh. Re
Koloproktologia.2023; 22(3): 10. CrossRef - Surgical Management of Small Bowel Crohn's Disease
Pramodh Chandrasinghe
Frontiers in Surgery.2022;[Epub] CrossRef - Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review
Abel Botelho Quaresma, Fernanda da Silva Barbosa Baraúna, Fábio Vieira Teixeira, Rogério Saad-Hossne, Paulo Gustavo Kotze
Journal of Clinical Medicine.2021; 10(4): 710. CrossRef - The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn’s Disease
Amy L. Lightner, Jon D. Vogel, Joseph C. Carmichael, Deborah S. Keller, Samir A. Shah, Uma Mahadevan, Sunanda V. Kane, Ian M. Paquette, Scott R. Steele, • Daniel L. Feingold
Diseases of the Colon & Rectum.2020; 63(8): 1028. CrossRef - Enterocutaneous fistula in severely active Crohn’s disease: preoperative anti-TNF alpha treatment to limit bowel resection—report of a case
Peter Wilhelm, Andreas Kirschniak, Jonas Johannink, Sascha Kaufmann, Thomas Klag, Jan Wehkamp, Claudius Falch
International Journal of Colorectal Disease.2019; 34(2): 369. CrossRef - Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries
Tawnya M Hansen, Laura E Targownik, Ahmer Karimuddin, Yvette Leung
Inflammatory Bowel Diseases.2019; 25(10): 1613. CrossRef - Gestion périopératoire des biothérapies en 2019
Thibault Martinez, Jean Derely, Astrée Swiech, Gaël de Roquigny, Charlotte Delattre, Frederic Banal, Mehdi Ould-Ahmed, Diane Commandeur
Anesthésie & Réanimation.2019; 5(4): 274. CrossRef - Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives
Alaa El-Hussuna, Pär Myrelid, Stefan D Holubar, Paulo G Kotze, Graham Mackenzie, Gianluca Pellino, Des Winter, Justin Davies, Ionut Negoi, Perbinder Grewal, Gaetano Gallo, Kapil Sahnan, Ines Rubio-Perez, Daniel Clerc, Nicolas Demartines, James Glasbey, Mi
Crohn's & Colitis 360.2019;[Epub] CrossRef - Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis
Paulo Gustavo Kotze, Christopher Ma, Nicholas Mckenna, Abdulelah Almutairdi, Gilaad G. Kaplan, Laura E. Raffals, Edward V. Loftus, Remo Panaccione, Amy L. Lightner
Therapeutic Advances in Gastroenterology.2018;[Epub] CrossRef - Emerging Therapies: What Are Promising in the Near Future?
Geom Seog Seo, Sung Hee Lee
The Korean Journal of Gastroenterology.2018; 71(2): 81. CrossRef - Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support
Patrick L. Stoner, Amir Kamel, Fares Ayoub, Sanda Tan, Atif Iqbal, Sarah C. Glover, Ellen M. Zimmermann
Gastroenterology Research and Practice.2018; 2018: 1. CrossRef
-
6,065
View
-
61
Download
-
9
Web of Science
-
11
Crossref
|
KASID
